AbbVie (ABBV) Net Margin (2012 - 2026)

AbbVie (ABBV) has 15 years of Net Margin data on file, last reported at 4.65% in Q1 2026.

• Net Margin for Q1 2026 came in at 4.65%, down 501.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 5.8% (down 153.0% YoY), and the FY2025 annual result was 6.92%, down 69.0% from the prior year.
• Net Margin eased to 4.65% in Q1 2026 per ABBV's latest filing, from 10.92% in the prior quarter.
• Over five years, Net Margin peaked at 33.19% in Q1 2022 and troughed at 0.79% in Q1 2023.
• A 5-year average of 10.52% and a median of 9.66% in 2025 frame the typical range for Net Margin.
• The sharpest annual moves came in 2023 and 2024: Net Margin plunged 3398 bps in 2023, then surged 1194 bps in 2024.
• A 5-year view of Net Margin shows it stood at 16.35% in 2022, then sank by 65 bps to 5.76% in 2023, then tumbled by 103 bps to 0.15% in 2024, then jumped by 7271 bps to 10.92% in 2025, then sank by 57 bps to 4.65% in 2026.
• Business Quant data shows ABBV's Net Margin at 4.65% in Q1 2026, 10.92% in Q4 2025, and 1.19% in Q3 2025.